Target intelligence / Profile preview

Androctonus crassicauda venom neurotoxins (Acra toxins)

Target
Acra toxins
Molecular classification
Neurotoxin, Voltage-gated sodium channel modulator, Voltage-gated potassium channel blocker, Peptide
01

Overview

Androctonus crassicauda venom neurotoxins are a complex mixture of potent peptides derived from the Arabian fat-tailed scorpion, primarily targeting voltage-gated sodium (Nav) and potassium (Kv) channels in the nervous system (PMID: 15530640). These toxins, including alpha- and beta-scorpion toxins, interfere with the normal gating mechanisms of ion channels, leading to persistent sodium currents and neuronal hyperexcitability (PMID: 21807027). This hyperexcitability triggers a massive systemic release of catecholamines and acetylcholine, often referred to as an autonomic storm, which can result in severe cardiovascular distress, pulmonary edema, and neuromuscular dysfunction. In a pharmacological context, these neurotoxins are the primary targets for antivenom therapy, where equine-derived antibodies or F(ab')2 fragments neutralize the toxins' ability to bind to their physiological receptors. The concept of paraspecificity is central to treatment, as antivenoms produced against A. crassicauda often exhibit cross-neutralization against structurally similar toxins from other medically important scorpion species within the Buthidae family (PMID: 19154718).

Other names
Arabian fat-tailed scorpion neurotoxinsAcra neurotoxinsButhidae scorpion toxinsBlack scorpion venom toxins
02

Mechanism of action

Antivenoms function by providing specific antibodies or antibody fragments (e.g., F(ab')2) that bind to and sequester circulating neurotoxins, forming non-toxic complexes that prevent the toxins from interacting with voltage-gated ion channels (PMID: 19154718).

03

Biological functions

Modulation of voltage-gated sodium channelsBlockade of voltage-gated potassium channelsInduction of neurotransmitter releaseProlongation of action potentials
04

Disease associations

Scorpion envenomationAutonomic nervous system stormCardiogenic shockPulmonary edemaNeurotoxicity
05

Safety considerations

Anaphylaxis to equine-derived antivenomSerum sicknessRapid systemic distribution of toxinsVariability in paraspecific neutralization efficacy
06

Interacting drugs

Androctonus crassicauda antivenom

3 more in the full profile.

07

Biomarkers

Serum venom concentrationCreatine kinase-MB (CK-MB)Cardiac troponin IHyperglycemiaElectrocardiogram (ECG) abnormalities

Beyond the preview

Go deeper on Androctonus crassicauda venom neurotoxins (Acra toxins).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Androctonus crassicauda venom neurotoxins (Acra toxins).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call